Detection of amyloid in Alzheimer’s disease with positron emission tomography using [11C]AZD2184
Open Access
- 5 June 2009
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 36 (11), 1859-1863
- https://doi.org/10.1007/s00259-009-1182-1
Abstract
Current positron emission tomography (PET) radioligands for detection of Aβ amyloid in Alzheimer’s disease (AD) are not ideal for quantification. To improve the signal to noise ratio we have developed the radioligand [11C]AZD2184 and report here the first clinical evaluation.Keywords
This publication has 8 references indexed in Scilit:
- [18F]Flumazenil binding to central benzodiazepine receptor studies by PET: – Quantitative analysis and comparisons with [11C]flumazenil –NeuroImage, 2009
- AZD2184: a radioligand for sensitive detection of β‐amyloid depositsJournal of Neurochemistry, 2009
- Radioligand Development for PET Imaging of β-Amyloid (Aβ)-Current StatusCurrent Medicinal Chemistry, 2007
- An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003Dementia and Geriatric Cognitive Disorders, 2006
- Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.2005
- Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-BJournal of Cerebral Blood Flow & Metabolism, 2005
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Synthesis of [11C]iodomethane by iodination of [11C]methaneApplied Radiation and Isotopes, 1997